European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
MSCI investment in Evora Global
We advised MSCI on the investment
NewMed Energy proposed combination with Capricorn Energy
We are advising NewMed on the transaction
Pon sale of interest in Hiller to Littlejohn & Co.
We advised Pon on the transaction
Tencent €300 million investment in Ubisoft
We are advising Tencent on the transaction
Gilead Sciences $405 million acquisition of MiroBio
We are advising Gilead Sciences on the transaction
Taibang Biologic Group $300 million equity raising
We are advising Taibang Biologic Group in connection with its equity raising by a group of investors
Pon sale of its flow control businesses to MiddleGround Capital
We advised Pon on the transaction
Dufry combination with Autogrill
We are advising Dufry on the transaction
RedBird Capital Partners acquisition of AC Milan from Elliott Advisors
We are advising an affiliate of Elliott Management on the transaction